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Most human endogenous retroviruses (HERVs) are ancient and their genes are rendered nonfunctional by debilitating mutations. One exception
is a recently discovered envelope gene located on chromosome 14. This envelope protein was also recently shown to be expressed in various
human tissues and to mediate cell–cell fusion ex vivo. In this study, we demonstrate that this locus (designated ERVPb1) is preserved in Old
World monkeys and that the reading frame is maintained. This is congruent with the entry of the HERV-P(b) group between 27 and 36 million
years ago as suggested by long terminal repeat divergence. Although the coding capacity is generally lost in the HERV-IP supergroup, the analysis
of nucleotide substitutions, lack of stop codons, and single-nucleotide polymorephisms strongly indicates a selective advantage of the ERVPb1
envelope genes during primate evolution. The purifying selection and tissue-specific expression of the human ERVPb1 envelope gene provide
strong evidence of a beneficial role for the host.
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Almost half of the human genome is repetitive and one of the
major repeat classes is human endogenous retroviruses
(HERVs). Most comply with the typical proviral organization
of an integrated retrovirus, which includes the gag, pol, and env
genes flanked by the long terminal repeat (LTR) structures.
Altogether, HERVs, solitary LTRs, and related retroelements
constitute 8% of the human genome [1]. Most human
endogenous retroviruses are ancient and presumably arose as
infections of the germline at least 25 million years ago [2]. Copy
numbers have increased by re-infection, by intracellular0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2005.08.011
i Sequence data from this article have been deposited with the GenBank Data
Library under Accession Nos. DQ247958, DQ247959, DQ247960, DQ247961,
and DQ247962.
* Corresponding author. Bioinformatics Research Center, University of
Aarhus, Høegh-Guldbergsgade 10, Building 090, DK-8000 Aarhus, Denmark.
Fax: +45 89423077.
E-mail address: palle@birc.au.dk (P. Villesen).
1 Contributed equally to this work.
2 Present address: Division of Molecular Biology, Beckman Research
Institute, City of Hope, Duarte, CA 91010, USA.transposition, or by means of retrotransposon processing in
trans [3,4] andmay range from a few tomore than thousands [2].
Most HERV loci are nonfunctional due to the accumulation
of debilitating mutations. No replication-competent HERVs
have yet been described, although fully intact members of the
evolutionarily younger HERV-K group have been reported [5].
Indeed, most of the intact viral open reading frames in the human
genome belong to the HERV-K group; however, of the 29
recently annotated full-length envelope genes, half are ancient
gammaretroviral loci [6]. An often cited example is ERV3 (a
HERV-R member), in which the gag and pol genes are littered
with stop codons, whereas the env reading frame is still open [7].
The preservation of an open envelope reading frame in an
otherwise degenerate proviral structure has led to speculations
about their possible beneficial role for the host. These include (i)
preventing retroviral infections by receptor blocking, (ii)
providing cells with immunomodulatory properties, or (iii)
being used as triggers to provide cell–cell fusion. Syncytin-1, an
Env-derived protein from the HERV-W group, provides a
striking example of the latter. Syncytin-1 is believed to mediate
formation of the syncytiotrophoblast layer during human
placenta formation [8,9] and may thus play an essential role in5) 685 – 691
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protein, syncytin-2, from the HERV-FRD group also shows
placenta-specific expression and may play a similar cell fusion
role [10]. There is also evidence to suggest that syncytin-1 may
provide protection against exogenous retroviruses by receptor
interference [11].
Expression of HERVs is linked with a number of human
diseases including various cancers and a number of autoimmune
disorders [12]. Although causal links between disease and
HERV activity remain to be established, it is clear from animal
models that expression of endogenous retroviral proteins can
affect cell proliferation and invoke or modulate immune
responses. Recent work by Anthony and colleagues [13]
indicates that syncytin-1 may be directly involved in neuronal
damage in multiple sclerosis patients by inducing release of
cytotoxic factors. HERV envelope proteins have also been
ascribed immunoregulatory properties such as the possible
superantigenic (SAg) activity of envelopes from HERV-K18
and HERV-W [14,15] and a functional CKS-17-like immuno-
suppressive motif in HERV-H Env, which prevents tumor
clearance in a murine cancer model [16].
Recently, we screened the human genome for retroviral
open reading frames and identified a number of intact and
almost intact gag, pol, and env genes [6]. Two new groups,
dubbed HERV-V and HERV-P(b), emerged from this study,
and their expression pattern and fusion properties were
recently tested [17]. Interestingly, this study demonstrated that
the HERV-P(b) envelope protein mediates cell–cell fusion ex
vivo. In this work, we demonstrate that the open envelope
reading frame at the ERVPb1 locus is fully conserved in Old
World monkeys. Comparative analysis of our data strongly
suggests that selection has preserved the envelope gene and weFig. 1. (A) Proviral organization of HERV-P(b1) provirus. The longest ORF within th
primate survey (1), expression analysis (2), and detection of a spliced transcript (3).
of primates. At the bottom are diagrams of SNPs in the human genome (bars) andspeculate that HERV-P(b) may have played a beneficial role
during primate evolution.
Results and discussion
In a recent annotation of open retroviral reading frames in the
human genome, we compiled a list of 29 intact or almost intact
envelope genes [6]. One of these is a long (664-amino-acid)
open reading frame found in a 5.9-kb-long provirus at
chromosome 14q32.12 (Fig. 1), which was recently demon-
strated to be fusion-competent [17]. Comparisons of the
transmembrane (TM) subunit to various envelope sequences
show that this provirus is member of the HERV-IP group [17].
This group comprises approximately 35 pol-containing mem-
bers in the human genome based on Southern blot analysis [18].
The envelope gene was dubbed envP(b) since the primer-
binding site matches tRNA-Pro at 11 of 15 positions and also in
order to distinguish it from the distantly related HERV-P group
[17]. We propose naming this locus ERVPb1 since the ERV-P(b)
group has three additional members in both the human and the
chimpanzee genomes (see Supplementary Table 1, Supplemen-
tary Fig. 1). Since human ERVPb1 harbors a large 2.8-kb
deletion within the pol gene, ‘‘classical’’ reverse transcriptase
(RT) taxonomy does not apply. However, the highly related
human provirus ERVPb2, a presumed predecessor, is seemingly
intact, and phylogenetic analysis of conserved motifs within RT
confirms classification to the HERV-IP group (data not shown).
The ERVPb1 envelope gene is conserved in Old World monkeys
Using the 2-kb human envelope DNA sequence from
ERVPb1 as a query, we searched the available genomes fore gag, pol, and env gene is indicated along with location of primers used for the
(B) Analysis of start and stop codons in all three reading frames for five species
the distribution of insertions and deletions (indels) in the alignment (arrows).
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were detected in the rodent, chicken, or fish genomes.
However, in the chimpanzee (Pan troglodytes) genome,
ERVPb1 is present at the homologous position on chromosome
15. We extended our search by screening a primate DNA panel
with PCR primers flanking the ERVPb1 envelope gene (Fig. 1,
Table 1). Indeed, we were able to amplify the expected 3-kb
amplicon from hominoids (gibbon, GenBank Accession No.
DQ247960) and Old World monkeys (African green monkey,
GenBank Accession No. DQ247961 and macaque, GenBank
Accession No. DQ247962). Interestingly, the envelope reading
frame is open in all species examined, and, importantly, several
predicted domains as reported by [10], such as the proteolytic
cleavage site (RKTR), the CKS-17-like immunosuppressive
domain, and the transmembrane region, are fully conserved
(Fig. 2, Supplementary Fig. 2). We also note that a CxxCxxxxP
(CWLC) motif conserved in gammaretroviruses is present in all
sequences [19]. Whereas all sequenced ERVPb1 envelope
proteins lack a canonical fusion peptide located at the N-
terminus of the putative TM subunit, there are two conserved
stretches of hydrophobic amino acids located further down-
stream (Fig. 2). One of these might act as an internal fusion
peptide as observed in flaviviruses [20]. Altogether, it is
possible that other primate species carry a functional ERVPb1
envelope protein as indicated by the fusiogenic properties of
human EnvP(b) [17].
We were unable to amplify the entire ERVPb1 envelope
gene from a New World monkey sample (owl monkey, Aotus
trivirgatus); however, locus-specific intra-envelope primers [as
also used for quantitative reverse transcription-polymerase
chain reaction (RT-PCR) analysis; Fig. 1] did amplify the
expected 100-bp envelope fragment from owl monkey DNA.
Comparative sequence analysis confirms that this fragment
most likely was amplified from ERVPb1 and we saw no stop
codons or frameshift mutations (data not shown). However,
limited sequence variation among the human and chimpanzee
ERV-P(b) members in this region and lack of flanking DNA
sequences make definitive locus assignment difficult. We also
attempted to PCR-amplify the long 3-kb and the short 100bp
envelope amplicon from various prosimian lemur species (ring-
tailed lemur, Lemur catta, and gray mouse lemur, Microcebus
murinus). All of these samples consistently showed no
amplicon, indicating that the ERV-P(b1) integration happenedTable 1
Sequence similarity of the ERVPb1 envelope gene in five species of primates
Human Chimpanzee Gibbon African
green
monkey
Macaque
Human 0.984 0.893 0.855 0.854
Chimpanzee 0.989 0.887 0.854 0.852
Gibbon 0.951 0.948 0.848 0.848
African
green
monkey
0.926 0.925 0.918 0.960
Macaque 0.923 0.923 0.917 0.981
Note. Protein identities are depicted in the upper triangle and DNA identities in
the lower triangle.after the catarrhine–strepsirhine split. Although caution should
be taken in interpreting these negative results, the presence of
ERV-P(b1) in catarrhines is in accordance with previously
reported results for other HERV-IP members using probe
hybridization techniques [18,21].
The ERVPb1 locus is 27–36 MY old
Using a divergence time of 20–25 MYA for the hominoid–
cercopithecoid split [22], we estimated the rate of evolution for
the 3V LTR region to 1.3  109 to 1.7  109 substitutions 
position1  million year1 (Supplementary Table 2). Assum-
ing a similar, clock-like rate of evolution between the 5V and the
3V LTR regions, we can estimate that the ERVPb1 provirus
entered the genome approximately 27–36 MYA (Fig. 3, Table
2). This is in accordance with the lack of ERV-P(b1) in
prosimians as suggested by our PCR survey and also the
absence of ERV-IPs in prosimians as shown by a recent
microarray-based analysis [21]. The remaining three HERV-
P(b) members show a similar level of divergence between the
5V and 3V LTRs (ranging from 10 to 12.5%, corrected),
indicating that this subgroup entered the genome within a
relatively short period of time. This is further substantiated by
the narrow branching order of the four members of the HERV-
P(b) clade within the HERV-IP group (Supplementary Fig. 1).
Evidence for selection within the ERVPb1 env gene
Within the coding regions only the env gene is intact. The
majority of the pol gene has been lost by a 2.8-kb deletion and
there is a density of >1 stop codon per 20 codons within the
gag gene and only residual reading frames remain (Fig. 1). The
four HERV-P(b) members contain only a single intact gene (the
ERVPb1 env), which surprisingly was found to be intact in all
species tested.
To further validate this strong indication of purifying
selection, we applied normal Ka/Ks tests for the entire env gene.
These did not indicate a clear pattern of significant deviation
from a Ka/Ks ratio ¨1, but subsequent site-specific analysis
revealed varying Ka/Ks ratios over the gene (Fig. 2). For
comparison, we also applied the classical Ka/Ks ratio test to the
syncytin-1 locus [23], which similarly shows no overall pattern
of significant purifying selection, whereas the syncytin-2 locus
[10] shows strong significance of selection (data not shown).
The strongest evidence of selection within the ERVPb1 env
gene comes from the patterns of human single-nucleotide
polymorphism (SNP) variation and insertions and deletions
between primate species. By mapping SNP polymorphisms
onto the human sequence, we observed that only 1 of 17 SNPs
falls within the envelope open reading frame (ORF) and that
single SNP is synonymous (Fig. 1). Assuming random
distribution of SNPs, the binomial probability of observing
this pattern (16 outside, 1 inside; ignoring nonsynonymous/
synonymous information) is significant (P = 0.011).
Furthermore, the alignment contains 14 insertion/deletions
events. Three of these do not disrupt the reading frame (i.e.,
indel length = n  3) and are located in the envelope region.
Fig. 2. Annotation and sliding-window analysis of alignment similarity, hydrophicity, and Ka/Ks ratios for the aligned ERVPb1 envelope genes.
L. Aagaard et al. / Genomics 86 (2005) 685–691688The remaining 11 all do disrupt the reading frame and all of
them are found outside the envelope region (Fig. 1). Assuming
random distribution of indels (i.e., assuming neutral selection),
the binomial probability of observing the 11 disrupting indels
outside and 0 disrupting indels inside the envelope ORF is
again significant (P = 0.00081).
Expression levels in human tissue samples
The recent report by [17] demonstrates that envP(b) is
widely expressed in human tissues. Our data (Supplementary
Fig. 3) confirm this ubiquitous expression, although there may
be minor differences in the relative expression levels between
tissues compared to the data from Blaise et al. [17]. Generally,Fig. 3. Maximum-likelihood tree of ERV-P(b1) envelope DNA sequences superimpo
the hominoid–cercopithecoid split was used to calculate the age of the ERVPb1 loenvP(b) expression is low but consistent in a wide range of
tissues and cell lines (Supplementary Fig. 3). When we
compare the expression to syncytin-1 levels in placental
RNA, envP(b) expression is roughly 100-fold lower (data not
shown). Interestingly, a closely related env-deficient element
(HERV-IP-T47D, Supplementary Table 1) is expressed and
packaged into virus particles that are spontaneously released
from mammary carcinoma-derived cells [18]. Since HERV-
P(b1) is the only HERV-IP member with an intact env gene, it
is possible that EnvP(b) could be involved in such tumor-
associated particle formation. As depicted in Fig. 1, the human
ERVPb1 provirus is flanked by two 425-bp LTRs. When
scanned for possible enhancer and promoter motifs, it seems
likely that the ERVPb1 5V LTR might still direct transcriptionalsed on primate phylogeny using cytochrome b sequences. The time estimate for
cus (see Table 2 and Supplementary Table 2).
Table 2
Age of ERVPb1 integration using intraspecific 5V–3V LTR divergences from
human and chimpanzee genome sequences
LTR divergence Substitution rate Age estimate
Human 0.0990 1.36  103 to 1.70  103 29.07–36.34
Chimpanzee 0.0882 1.31  103 to 1.64  103 26.95–33.69
Note. Substitution rates are based on the interspecific LTR divergence
(Supplementary Table 2) and a divergence time of the hominoid–cercopithe-
coid split of 20–25 MYA [22].
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mentary Fig. 4). To address the question of whether the
envelope-specific transcript, detected by RT-qPCR primers by
us and by Blaise et al. [17], might stem from a spliced and
hence in vivo translation-competent RNA, we performed RT-
qPCR using a primer set spanning the viral leader and the
envelope gene. Indeed, we detect a 500-bp band, which is
consistent with splicing from a putative splice-donor site in the
leader region just upstream of the first AUG site in env.
Concluding remarks
We have amplified and sequenced the envP(b) gene located
on chromosome 14q32.12 (previously named ZFERV-like Env)
from hominoids (gibbon) and Old World monkeys (African
green monkey and macaque). We propose naming this locus
ERVPb1. Our data surprisingly demonstrate that the ERVPb1
envelope reading frame is open and intact in all species
examined (Fig. 1), and a detailed comparative analysis suggests
that parts of this gene have been subjected to purifying
selection to maintain the amino acid composition (Ka/Ks < 1,
Fig. 2). Some of the conserved regions coincide with known
motifs from infectious retroviral envelope proteins such as the
CxxCxxxxP region, the immunosuppressive motif, and the
transmembrane region. Taken together with the recently
described ability of human EnvP(b) to fuse cells ex vivo
[17], it is plausible that the primate EnvP(b) proteins may also
mediate cell–cell fusion or even infectivity. We are currently
testing this hypothesis. Moreover, the deviation from neutral
selection at this locus is clearly demonstrated by significant
lack of insertions and deletions (indels) and SNPs within the
envelope gene compared to the flanking proviral sequence
(Fig. 1).
Using a locus-calibrated molecular clock and by assuming
identical LTR at the time of integration, the level of divergence
between the flanking LTRs leads to an age estimate of ERVPb1
of approximately 30 MY. This suggests that ERVPb1 may also
be present in New World monkeys. Indeed, we do detect a 100-
bp ERV-P(b) fragment in owl monkeys. This observation
warrants further investigations into the presence or absence of
an intact envelope gene in New World monkeys.
We confirm the data from Blaise et al. [17] that the human
ERVPb1 gene is expressed in a tissue-specific manner. The
positive expression in placenta is particularly interesting since
two other fusiogenic envelope proteins, syncytin-1 and -2, are
also expressed in this tissue. Syncytin-1 and -2 have been
suggested to play a role in placenta formation by mediatingfusion of trophoblast cells [8–10]. Thus, considering the strong
evolutionary conservation of ERVPb1, it is possible that
EnvP(b) plays a similar physiological role. However, as noted
by [17], the ubiquitous pattern of expression does not resemble
the placenta-specific expression observed for the two syncytin
genes. Furthermore, the levels of expression in the placenta are
approximately 100-fold lower than that observed for syncytin-
1. Our data suggest that the human ERVPb1 gene is in fact
most highly expressed in the thymus. The physiological
implications of thymic expression, if any, are not clear,
although an immunological component could be suggested.
Almost all of the intact non-HERV-K retroviral reading
frames present in the human genome are envelope proteins [6].
A physiological role as a trigger for cell–cell fusion has been
suggested for the intact HERV-W and HERV-FRD envelope
genes (syncytin-1 and -2), as discussed above. Expression of an
endogenous envelope protein may also protect against a related
disease-causing virus by receptor blockage. Wild mice expres-
sing the Fv4 envelope gene are thus less susceptible to infection
by murine leukemia virus [24]. Syncytin-1 expression has in
fact been shown to provide infection resistance toward the avian
spleen necrosis virus [11], and a similar role could apply to
other envelope loci that presumably still recognize a cellular
receptor such as Syncytin-2 and EnvP(b). Alternative functional
roles for endogenous envelope proteins that may turn out to be
unrelated to retroviral biology may also await discovery.
The data presented here show that the intact EnvP(b) ORF is
not only conserved in humans, but has remained intact for
millions of years in all species studied. The simplest and most
likely explanation is that it is a functional gene. Altogether, our
evolutionary analysis provides compelling evidence that an
intact EnvP(b) gene plays a beneficial role in simians, but
exactly how this effect is mediated must await further
investigations.
Materials and methods
DNA samples, PCR amplification, and sequencing
DNA from gibbon (Hylobates gabriellae) and macaque (Macaca nemes-
trina) was a gift from Max Planck Institute for Evolutionary Anthropology
(Leipzig), tissue from ring-tailed lemur (Lemur catta) was a gift from Living
United/Ebeltoft Zoo & Safari (DNA was isolated using a QIAGEN tissue
isolation kit), DNA from gray mouse lemur (Microcebus murinus) was kindly
donated by Tina Fredsted, DNA from owl monkey (Aotus trivirgatus) was
purchased from ECACC (OMK 637-69), and DNA from African green monkey
(Cercopithecus aethiops) was isolated from COS cells (using Invitrogen
DNAzol). All primate DNA samples were verified by amplification and direct
sequence analysis of the cytochrome oxidase I (COI) gene. Sequences from
human (Homo sapiens) and chimpanzee (Pan troglodytes) were extracted from
the ENSEMBL genome database (http://www.ensembl.org). Primers were
designed to amplify EnvP(b1) and a part of the 3V flanking region including the
3V LTR region (No. 1, Table 3). The PCR was preformed by the use of rTth
DNA Polymerase, XL (Applied Biosystem) in 100-Al reaction using 300 nM
primer, 0.2 mM dNTP, 5 Al of Mg(OAc)2, 150 ng of DNA, and buffers by the
supplier. The PCR program was as follows: 1 cycle (94-C for 1 min), 35 cycles
(94-C for 1 min; 60-C for 1 min; 72-C for 5 min), and 1 cycle (72-C for 10
min). Resulting PCR products (3 kb) were directly sequenced from a 5-Al PCR
mixture using the ET sequencing kit (Amersham) according to the manufacturer
(details for sequence primers are available from the authors upon request) and
analyzed on an ABI3100 (Applied Biosystems). All ERVPb1 sequences have
Table 3
Primers used for the ERVPb1 primate survey and human expression analysis
Name Sequence (5V–3V)
No. 1 forward GGTCCCTGATCCCTACATGTGGCACAGCTCAGAGC
No. 1 reverse CCAAAGAGTGCTGGAGCCAAACAGTACCAAAGGAGG
No. 2 forward TCTTTCCTTGTGCTCTTGCTAGCCA
No. 2 reverse GGCTTTGGAGATCCCCACAAGGTA
No. 3 forward TTTCACTTCACAGCACTGACAATTTGT
No. 3 reverse Identical to No. 2 reverse
COI forward CCCCGAATAAACAATATAAGCTTCTG
COI reverse AAAAATCAGAATAGGTGTTGGTATAG
h-Actin
forward
CCGCCAGCTCACCATGGATGAT
h -Actin
reverse
CTTCTGACCCATGCCCACCA
GAPDH
forward
GTCAGCCGCATCTTCTTTTG
GAPDH
reverse
GCGCCCAATACGACCAAATC
Syncytin-1
forward
CCCCATCGTATAGGAGTCTT
Syncytin-1
reverse
CCCCATCAGACATACCAGTT
L. Aagaard et al. / Genomics 86 (2005) 685–691690been deposited with the GenBank Data Library under the following accession
numbers: (human ERVPb1, GenBank Accession No. DQ247958), (chimpanzee
ERVPb1, GenBank Accession No. DQ247959), (gibbon ERVPb1, GenBank
Accession No. DQ247960), (African green monkey ERVPb1, GenBank
Accession No. DQ247961), and (macaque ERVPb1, GenBank Accession No.
DQ247962).
Expression analysis using quantitative RT-PCR
RNA samples from various human cell lines were isolated using TriZol
Reagent (Invitrogen). RNA from 24 different human tissues (Total RNA
Master Panels II) was obtained from BD Biosciences. All RNA samples were
treated with TURBO DNase 1U (Ambion) for 30 min at 37-C, phenol/
chloroform extracted, ethanol precipitated, and dissolved in nuclease-free
water (Ambion). One microgram of RNA was reverse-transcribed using the
M-MLV reverse transcriptase (Invitrogen) using random hexamer primers.
The resulting cDNA was diluted so that 1 Al corresponded to 17 ng of total
RNA. RT-qPCR analysis was performed on a MX4000 (Strategene) using 10
Al cDNA, 100 nM primers (No. 2, Table 3) and SYBR Green (Stratagene) in
a 25-Al reaction according to the manufacturer’s instructions. The PCR
program was as follows: 1 cycle (94-C for 10 min) and 40 cycles (94-C for
0.5 min; 60-C for 1 min; 72-C for 0.5 min). As an internal control,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and h-actin genes were
also amplified (data not shown). The relative expression in each sample was
calculated with respect to a standard calibration curve (a dilution series of
genomic DNA). Each sample was analyzed twice, and the PCR products were
sequenced to verify the target specificity. To detect a spliced envelope
transcript, we amplified an ¨500-bp product using a forward primer upstream
of the putative splice-donor site and a reverse primer within the envelope
reading frame (No. 3) from the placental cDNA sample.
Evolutionary analysis
Sequences were aligned using ClustalW [25] and alignment similarity plots
and protein hydrophobicity plots were created using the EMBOSS package
[26]. The Ka/Ks ratio data were calculated using PAML [27] and a sliding
window of 17 aa. To test for evolutionary conservation of the ORF, we
downloaded human SNP data from ENSEMBL (http://www.ensembl.org) and
identified reading-frame-disrupting indels in the alignment. Assuming a
random distribution of SNPs and insertion/deletions, we calculated the P
values as the binomial probability of the observed SNP and insertion/deletion
patterns. Promoter and enhancer predictions for the LTR regions were carriedout using TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html) and
ALIBABA2 (http://www.alibaba2.com).
ML phylogenies were created using PHYLIP [28] with default parameters.
The ERVPb1 envelope tree was based on the envelope DNA (alignment length:
2000 bp). A primate tree of the cytochrome b DNA was also constructed for
comparison with the primate phylogeny. The HERV-IP envelope tree was based
on a manually inspected envelope DNA (alignment length: 727 bp) to
accommodate alignment to the outgroup HERV-ADP. References to all
sequences are provided in Supplementary Table 1.
Substitution rates were estimated using data from five species of primates
and using a divergence time of 20–25 MYA of the hominoid–cercopithecoid
split [22]. The HERV integration time was then calculated from the LTR
divergence (since the LTRs were assumed to be identical when the HERV was
integrated) and the estimated substitution rate (Kimura 2 parameter).Acknowledgments
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